These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32530401)

  • 1. Is ABO blood group a risk or prognostic factor for patients with endometrioid endometrial cancer? A retrospective analysis in Germany.
    Gitas G; Proppe L; Alkatout I; Tsolakidis D; Rody A; Kotanidis C; Baum S
    Blood Transfus; 2020 Nov; 18(6):465-470. PubMed ID: 32530401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study.
    Tal O; Eitan R; Gemer O; Helpman L; Vaknin Z; Leytes S; Lavie O; Ben-Arie A; Amit A; Namazov A; Ben Shahar I; Atlas I; Bruchim I; Levy T
    Int J Gynecol Cancer; 2021 Nov; 31(11):1437-1442. PubMed ID: 34725243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
    Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
    Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic impact of ABO blood group on type I endometrial cancer in a population of Iranian patients.
    Mohammadian S; Pouresmaeili F; Mohammadian A
    Hum Antibodies; 2020; 28(4):313-317. PubMed ID: 32508322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening.
    Carr C; Son J; Yao M; Priyadarshini A; Marquard J; Vargas R; Michener C; AlHilli MM
    Gynecol Oncol; 2020 Dec; 159(3):712-720. PubMed ID: 33046272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodal metastasis in endometrial cancer.
    Willis G; Misas JE; Byrne W; Podczaski E
    Eur J Gynaecol Oncol; 2011; 32(3):259-63. PubMed ID: 21797112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of uterine manipulator on oncological outcome in endometrial cancer surgery.
    Padilla-Iserte P; Lago V; Tauste C; Díaz-Feijoo B; Gil-Moreno A; Oliver R; Coronado P; Martín-Salamanca MB; Pantoja-Garrido M; Marcos-Sanmartin J; Gilabert-Estellés J; Lorenzo C; Cazorla E; Roldán-Rivas F; Rodríguez-Hernández JR; Sánchez L; Muruzábal JC; Hervas D; Domingo S;
    Am J Obstet Gynecol; 2021 Jan; 224(1):65.e1-65.e11. PubMed ID: 32693096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.
    Kurnit KC; Kim GN; Fellman BM; Urbauer DL; Mills GB; Zhang W; Broaddus RR
    Mod Pathol; 2017 Jul; 30(7):1032-1041. PubMed ID: 28281553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative Anemia as a Prognostic Factor in Endometrioid-Type Endometrial Carcinoma.
    Abu-Zaid A; Alsabban M; Abuzaid M; Alomar O; Salem H; Al-Badawi IA
    J Obstet Gynaecol Can; 2018 Nov; 40(11):1393-1400. PubMed ID: 30473117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma.
    Abu-Zaid A; Alsabban M; Abuzaid M; AlOmar O; Salem H; Al-Badawi IA
    Ann Saudi Med; 2017; 37(5):393-400. PubMed ID: 28988254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors related to recurrence in non-obese women with endometrial endometrioid adenocarcinoma.
    Panggid K; Cheewakriangkrai C; Khunamornpong S; Siriaunkgul S
    J Obstet Gynaecol Res; 2010 Oct; 36(5):1044-8. PubMed ID: 21058438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of inflammatory parameters and nutritional index in clinical stage IVB endometrial carcinomas.
    Kiuchi K; Hasegawa K; Ochiai S; Motegi E; Kuno T; Kosaka N; Fukasawa I
    J Obstet Gynaecol; 2019 Feb; 39(2):237-241. PubMed ID: 30370797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influences of uterine adenomyosis on muscle invasion and prognosis of endometrioid adenocarcinoma.
    Taneichi A; Fujiwara H; Takahashi Y; Takei Y; Machida S; Saga Y; Takahashi S; Suzuki M
    Int J Gynecol Cancer; 2014 Oct; 24(8):1429-33. PubMed ID: 25188882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of prognostic factors in poorly differentiated (G3) endometrioid adenocarcinoma in Japan.
    Kuwabara Y; Susumu N; Banno K; Hirao T; Kawaguchi M; Yamagami W; Suzuki N; Aoki D; Nozawa S
    Jpn J Clin Oncol; 2005 Jan; 35(1):23-7. PubMed ID: 15681600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Survival Outcomes of Uterine Papillary Serous Carcinoma, Clear Cell Carcinoma, Grade 3 Endometrioid Adenocarcinoma, and Carcinosarcoma of Endometrial Cancer in Rajavithi Hospital.
    Prueksaritanond N; Chantape W
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S75-83. PubMed ID: 27266220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical patterns and genomic profiling of recurrent 'ultra-low risk' endometrial cancer.
    Stasenko M; Feit N; Lee SSK; Shepherd C; Soslow RA; Cadoo KA; Alektiar K; Da Silva EM; Martins Sebastião AP; Leitao MM; Gardner G; Selenica P; Abu-Rustum NR; Weigelt B; Mueller JJ
    Int J Gynecol Cancer; 2020 Jun; 30(6):717-723. PubMed ID: 32376737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA ploidy is an independent prognostic indicator of overall survival in stage I endometrial endometrioid carcinoma.
    Santala M; Talvensaari-Mattila A
    Anticancer Res; 2003; 23(6D):5191-6. PubMed ID: 14981988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
    Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
    Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.